Adtalem Global Education Inc.

08/07/2025 | Press release | Distributed by Public on 08/07/2025 14:23

Material Agreement, Financial Obligation (Form 8-K)

Exhibit 99.1

Investor Contact : Jay Spitzer

[email protected]

+1 312-906-6600

Media Contact: Jason Carr

[email protected]

+1 773-858-7932

Adtalem Global Education Announces Exceptional Fiscal Year 2025 Results;

Initiates Fiscal Year 2026 Guidance

Total enrollment up 10.2% YoY for fourth quarter 2025

Revenue up 12.9% YoY for fiscal 2025

Fiscal 2025 diluted earnings per share $6.18; Adjusted EPS $6.67, growth of 33.1% YoY

Fourth quarter highlights

Revenue $457.1 million, up 11.5% year-over-year
Total student enrollment 91,780, up 10.2% year-over-year
Chamberlain tenth straight quarter of total enrollment growth, up 5.8% year-over-year
Walden eighth straight quarter of total enrollment growth, up 15.0% year-over-year
Medical and Veterinary sustained total enrollment growth, up 1.0% year-over-year
GAAP net income $54.2 million; adjusted EBITDA $110.2 million, up 13.2% year-over-year

Fiscal year highlights

Revenue $1,788.3 million, up 12.9% year-over-year
Chamberlain achieved record total enrollment, more than 40,500 enrolled
Walden total enrollment up double digits every quarter, achieving more than 48,500 enrolled
Medical and Veterinary approx. 5,000 students enrolled on average
Growth with Purpose momentum, GAAP net income $237.1 million; adjusted EBITDA $459.7 million, up 21.8% year-over-year

Fiscal year capital allocation

Repurchased $211 million of shares completing prior authorization; new $150 million Board authorization through May 2028
Repriced $253 million Term Loan B on Aug. 21, 2024, reducing interest rate by 75 bps; repaid $100 million of outstanding Term Loan B balance on Jan. 17, 2025
Net leverage 0.8x as of June 30, 2025

Fiscal year '26 guidance

Revenue $1,900 million to $1,940 million
Adjusted earnings per share $7.60 to $7.90

CHICAGO - Aug. 7, 2025 - Adtalem Global Education Inc. (NYSE: ATGE), the leading healthcare educator in the United States, today reported fourth quarter and fiscal 2025 results (ended June 30, 2025) achieving exceptional results through sustained total enrollment growth, increased operational efficiency and strong student outcomes through disciplined strategic execution.

"Fiscal 2025 marked a defining moment for Adtalem-an inflection point that demonstrated the strength and scaled ability of our Growth with Purpose strategy," said Steve Beard, chairman and chief executive officer of Adtalem Global Education. "We delivered strong financial results while deepening our impact-graduating more healthcare professionals into roles where they're urgently needed. Our disciplined investments and student outcomes, coupled with strategic partnerships, are creating repeatable high return pathways from education to employment. With a resilient operating model and growing momentum, we are well-positioned to sustain performance and deliver long-term value for our students, shareholders and the U.S. healthcare system."

Financial Highlights

Selected financial data for the three months ended June 30, 2025:

Revenue was $457.1 million, an increase of 11.5% compared with the prior year.
Operating income was $76.9 million, compared with $68.5 million in the prior year; adjusted operating income was $87.5 million, compared with $80.1 million in the prior year.
Net income was $54.2 million, compared with $49.4 million in the prior year; adjusted net income was $62.4 million, compared with $52.8 million in the prior year.
Diluted earnings per share was $1.44, compared with $1.28 in the prior year; adjusted earnings per share was $1.66, compared with $1.37 in the prior year.
Adjusted EBITDA was $110.2 million, compared with $97.4 million in the prior year; adjusted EBITDA margin was 24.1%, compared with 23.8% in the prior year.

Selected financial data for the fiscal year ended June 30, 2025:

Revenue was $1,788.3 million, an increase of 12.9% compared with the prior year.
Operating income was $341.5 million, compared with $217.1 million in the prior year; adjusted operating income was $370.2 million, compared with $308.8 million in the prior year.
Net income was $237.1 million, compared with $136.8 million in the prior year; adjusted net income was $255.6 million, compared with $201.8 million in the prior year.
Diluted earnings per share was $6.18, compared with $3.39 in the prior year; adjusted earnings per share was $6.67, compared with $5.01 in the prior year.
Adjusted EBITDA was $459.7 million, compared with $377.5 million in the prior year; adjusted EBITDA margin was 25.7%, compared with 23.8% in the prior year.

Business Highlights

Chamberlain University and SSM Health announced the Aspiring Nurse Program - a groundbreaking partnership designed to address critical healthcare workforce needs. The innovative partnership funds nursing education1, enhances clinical readiness and creates a
pathway to employment across SSM Health's care sites in Missouri, Oklahoma, Illinois and Wisconsin. The partnership offers a direct, employment-focused pathway for aspiring nurses, creating a sustainable talent pipeline that will graduate more than 400 new nurses annually.
Walden University and Chamberlain University earned the prestigious "Opportunity Colleges and Universities" designation in the 2025 Carnegie Classification. This selective recognition from the Carnegie Foundation and American Council on Education, awarded to only 16% of institutions assessed, confirms Chamberlain and Walden's ability to serve broad student populations while delivering strong economic outcomes for graduates.
Walden University's Doctor of Social Work (DSW) program has achieved accreditation by the Council on Social Work Education (CSWE), making it one of only four DSW programs in the U.S. to receive this recognition. This accreditation validates the quality of the DSW program and the professional excellence of its graduates.
Adtalem's Medical and Veterinary schools (American University of the Caribbean School of Medicine, Ross University School of Medicine and Ross University School of Veterinary Medicine) graduated more than 1,100 students in fiscal year 2025. Medical students from 42 states and 30 countries and veterinary students from 43 states and four countries, were amongst the graduating class.2
American University of the Caribbean School of Medicine (AUC) has collaborated with Massachusetts General Hospital Institute of Health Professions (MGH Institute of Health Professions) to create the MGHIHP-AUC-Gateway for Innovation Careers in Medical Technology ("MAGIC") partnership, providing AUC students the ability to pursue a Master's in Healthcare Data Analytics (MSDA) which can be completed while students complete their Doctor of Medicine (MD) degree. The partnership places AUC students and alumni at the forefront of the AI digital transformation in healthcare, shaping the future of medicine.

Segment Highlights

Chamberlain

$ in millions

Three Months Ended

June 30,

Year Ended

June 30,

2025

2024

% Change

2025

2024

% Change

Revenue

$184.3

$167.0

10.3%

$725.8

$633.5

14.6%

Operating Income

$35.7

$40.5

(11.7)%

$151.5

$137.8

9.9%

Adj. Operating Income

$35.7

$40.5

(11.7)%

$153.4

$137.8

11.3%

Adj. EBITDA

$45.0

$47.3

(4.8)%

$191.4

$166.2

15.2%

Total Students (3)

38,891

36,750

5.8%

Total student enrollment increased 5.8% compared with the prior year, driven by continued growth in pre-licensure and post-licensure nursing programs.

Walden

$ in millions

Three Months Ended

June 30,

Year Ended

June 30,

2025

2024

% Change

2025

2024

% Change

Revenue

$182.2

$156.3

16.6%

$693.4

$595.3

16.5%

Operating Income

$44.0

$30.1

46.3%

$177.9

$77.2

130.5%

Adj. Operating Income

$46.8

$37.4

25.1%

$183.6

$130.5

40.6%

Adj. EBITDA

$52.7

$41.1

28.0%

$206.5

$146.8

40.7%

Total Students (3)

48,116

41,845

15.0%

Total student enrollment increased 15.0% compared with prior year, driven by growth in healthcare and non-healthcare programs.

Medical and Veterinary

$ in millions

Three Months Ended

June 30,

Year Ended

June 30,

2025

2024

% Change

2025

2024

% Change

Revenue

$90.6

$86.6

4.7%

$369.1

$355.8

3.7%

Operating Income

$14.9

$11.9

24.7%

$68.8

$71.1

(3.2)%

Adj. Operating Income

$15.1

$12.0

25.8%

$69.3

$71.5

(3.2)%

Adj. EBITDA

$20.0

$16.5

21.7%

$88.8

$88.9

(0.1)%

Total Students (3)

4,773

4,726

1.0%

Total student enrollment increased 1.0% compared with the prior year, driven by growth at medical and veterinary.

Fiscal Year 2026 Outlook

Adtalem initiates guidance for fiscal year 2026, revenue in the range of $1,900 million to $1,940 million, approximately 6.0% to 8.5% growth year-over-year. Adjusted earnings per share to be in the range of $7.60 to $7.90, approximately 14.0% to 18.5% growth year-over-year.

Conference Call and Webcast Information

Adtalem will hold a conference call to discuss its fourth quarter and fiscal year 2025 results today at 4:00 p.m. CT (5:00 p.m. ET).

The call can be accessed by dialing +1 877-407-6184 (U.S. participants) or +1 201-389-0877 (international participants) and stating "Adtalem earnings call" or by using conference ID: 13754556. The call will be simulcast through the Adtalem investor relations website at: https://investors.adtalem.com.

Adtalem will archive a replay of the call for 30 days. To access the replay, dial +1 877-660-6853 (U.S.) or +1 201-612-7415 (international), conference ID: 13754556, or visit the Adtalem investor relations website.

About Adtalem Global Education

Adtalem Global Education is the leading provider of healthcare education in the U.S., shaping the future of healthcare by preparing a workforce with high-quality academic programs. We innovate education pathways, align with industry needs and empower individuals to reach their full potential. Our commitment to excellence and access is reflected in our expansive network of institutions, serving over 90,000 students and supported by a strong community of approximately 365,000 alumni and nearly 10,000 dedicated employees. Visit Adtalem.com for more information and follow us on LinkedIn, Instagram and Facebook.

Adtalem Global Education Inc. published this content on August 07, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on August 07, 2025 at 20:24 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]